Satoshi Yanagida

750 total citations
15 papers, 210 citations indexed

About

Satoshi Yanagida is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Satoshi Yanagida has authored 15 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 5 papers in Molecular Biology. Recurrent topics in Satoshi Yanagida's work include Ovarian cancer diagnosis and treatment (6 papers), Uterine Myomas and Treatments (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Satoshi Yanagida is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Uterine Myomas and Treatments (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Satoshi Yanagida collaborates with scholars based in Japan, United States and Canada. Satoshi Yanagida's co-authors include Aikou Okamoto, Chie Nagata, Hiroshi Hayashi, Tadao Tanaka, Nozomu Yanaihara, Yasushi Iida, Shigehisa Okamoto, Kazunori Ochiai, Kazuaki Takahashi and Jiro Suzuki and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of Oncology.

In The Last Decade

Satoshi Yanagida

15 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Yanagida Japan 9 127 103 63 29 29 15 210
Emily Berry United States 8 107 0.8× 106 1.0× 71 1.1× 36 1.2× 28 1.0× 16 253
Baoxia Gu China 4 88 0.7× 106 1.0× 64 1.0× 40 1.4× 24 0.8× 6 238
Deborah Neesham Australia 7 201 1.6× 153 1.5× 34 0.5× 45 1.6× 25 0.9× 15 281
Nina Ewald-Riegler Germany 8 206 1.6× 113 1.1× 34 0.5× 47 1.6× 32 1.1× 12 273
Elizabeth C. Sefton United States 6 231 1.8× 244 2.4× 39 0.6× 14 0.5× 17 0.6× 9 308
Vladimir Nosov Russia 3 87 0.7× 29 0.3× 50 0.8× 16 0.6× 11 0.4× 6 134
Marieke G. M. Braem Netherlands 4 55 0.4× 26 0.3× 27 0.4× 55 1.9× 23 0.8× 4 135
Jakkapan Khunnarong Thailand 11 87 0.7× 117 1.1× 45 0.7× 57 2.0× 6 0.2× 26 234
P.M.L.H. Vencken Netherlands 5 130 1.0× 19 0.2× 71 1.1× 101 3.5× 26 0.9× 6 234
Maria Pilar Barretina-Ginesta Spain 6 69 0.5× 58 0.6× 49 0.8× 53 1.8× 4 0.1× 9 151

Countries citing papers authored by Satoshi Yanagida

Since Specialization
Citations

This map shows the geographic impact of Satoshi Yanagida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Yanagida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Yanagida more than expected).

Fields of papers citing papers by Satoshi Yanagida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Yanagida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Yanagida. The network helps show where Satoshi Yanagida may publish in the future.

Co-authorship network of co-authors of Satoshi Yanagida

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Yanagida. A scholar is included among the top collaborators of Satoshi Yanagida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Yanagida. Satoshi Yanagida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ito, Hiroe, et al.. (2024). Validate robot-assisted total laparoscopic hysterectomy with four equally-spaced ports without an assistant port. Journal of Robotic Surgery. 18(1). 55–55. 1 indexed citations
2.
Yanaihara, Nozomu, Yuki Yoshino, Junya Tabata, et al.. (2022). Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway. Gynecologic Oncology. 168. 83–91. 8 indexed citations
3.
Ito, Kimihiko, Mototsugu Shimokawa, Satoshi Yanagida, et al.. (2022). Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601. Anti-Cancer Drugs. 34(7). 857–865. 2 indexed citations
4.
Takenaka, Masataka, Yasushi Iida, Nozomu Yanaihara, et al.. (2021). Re-thinking the prognostic significance of positive peritoneal cytology in endometrial cancer. Gynecologic Oncology. 161(1). 135–142. 15 indexed citations
5.
Seki, Toshiyuki, Nozomu Yanaihara, Jason Shapiro, et al.. (2021). Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma. Scientific Reports. 11(1). 7689–7689. 24 indexed citations
6.
Ito, Hiroe, et al.. (2021). Single assistant versus dual assistant robotic surgery for robot‐assisted laparoscopic hysterectomy using da Vinci Xi or X. International Journal of Medical Robotics and Computer Assisted Surgery. 17(6). e2315–e2315. 3 indexed citations
7.
Ito, Kimihiko, Masafumi Nakagawa, Satoshi Yanagida, et al.. (2020). 834P A phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear-cell carcinoma (KCOG-G1601 trial). Annals of Oncology. 31. S627–S627. 1 indexed citations
8.
Yanagida, Satoshi, Michael S. Anglesio, Tayyebeh M. Nazeran, et al.. (2017). Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation. PLoS ONE. 12(6). e0178989–e0178989. 11 indexed citations
9.
Nagata, Chie, et al.. (2015). Use of dienogest over 53 weeks for the treatment of endometriosis. Journal of obstetrics and gynaecology research. 41(12). 1921–1926. 46 indexed citations
10.
Koyama‐Nasu, Ryo, Rina Takahashi, Satoshi Yanagida, et al.. (2013). The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels. PLoS ONE. 8(1). e53710–e53710. 13 indexed citations
11.
Yanagida, Satoshi, Kenzui Taniue, Yasuko Takeda, et al.. (2013). ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma. Scientific Reports. 3(1). 1305–1305. 20 indexed citations
12.
Nagata, Chie, Satoshi Yanagida, Aikou Okamoto, et al.. (2012). Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest. Journal of obstetrics and gynaecology research. 38(4). 639–644. 34 indexed citations
13.
Tanaka, Tadao, Satoshi Yanagida, & Nozomu Yanaihara. (2012). [The general rules for clinical and pathological management of trophoblastic diseases--2011, the 3rd edition].. PubMed. 70 Suppl 4. 695–8. 2 indexed citations
14.
Hirata, Yukihiro, Nozomu Yanaihara, Satoshi Yanagida, et al.. (2012). Molecular Genetic Analysis of Nongestational Choriocarcinoma in a Postmenopausal Woman. International Journal of Gynecological Pathology. 31(4). 364–368. 13 indexed citations
15.
Yamada, Kenichiro, Toshiaki Tachibana, Keitaro Suzuki, et al.. (1999). Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary.. PubMed. 12(3). 131–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026